Literature DB >> 31361827

The opioid crisis: Origins, trends, policies, and the roles of pharmacists.

Marie A Chisholm-Burns1, Christina A Spivey2, Erin Sherwin1, James Wheeler3, Kenneth Hohmeier4.   

Abstract

PURPOSE: The purpose of this review is to (1) provide information concerning the opioid crisis including origins, trends, and some important related laws/policies; and (2) summarize the current involvement and impact of pharmacists in helping to address the crisis, as well as examine practices in other healthcare disciplines from which pharmacists might derive guidance and strategies.
SUMMARY: Contributors to the opioid crisis included campaigns to treat pain as a fifth vital sign and to use opioids in treatment of non-cancer-related pain, as well as aggressive marketing of opioid analgesics by pharmaceutical companies. To address the crisis, numerous strategies have been implemented at the policy/legislative, health-system, and patient levels, such as prescription drug monitoring programs (PDMPs), increased regulation of pain clinics, and expanded use of naloxone. Pharmacists have a critical role to play in interventions to address opioid misuse and reduce harm resulting from misuse. Such interventions include patient screening and risk stratification, patient and community education and outreach concerning appropriate pain management, medication reviews/medication therapy management, education on safe storage and disposal, distribution of naloxone/opioid rescue kits and training on their proper use, and referral of patients to addiction treatment, among other strategies.
CONCLUSION: Pharmacists have multiple, complex roles in addressing the opioid crisis. Outcomes of several studies provide substantial evidence that pharmacists can make an impact through appropriate pain management, use of PDMPs, opioid overdose prevention training, and medication reviews and counseling, among other interventions. © American Society of Health-System Pharmacists 2019. All rights reserved. For permissions, please e-mail: journals.permissions@oup.com.

Entities:  

Keywords:  opioids; pain management; patient education; pharmacists; policy; prescribers

Mesh:

Substances:

Year:  2019        PMID: 31361827     DOI: 10.1093/ajhp/zxy089

Source DB:  PubMed          Journal:  Am J Health Syst Pharm        ISSN: 1079-2082            Impact factor:   2.637


  16 in total

1.  Clinical impact of a personalized pharmaceutical plan on opioid management in non-cancer pain: a pilot study.

Authors:  Claire Lattard; Catherine Chenailler; Annaelle Soubieux; Andre Gillibert; Henri Gondé; Marie Kozyreff-Meurice; Sophie Pouplin; Thierry Lequerré; Rémi Varin; Olivier Vittecoq
Journal:  Clin Rheumatol       Date:  2021-05-25       Impact factor: 2.980

2.  Association between Posttransplant Opioid Use and Immunosuppressant Therapy Adherence among Renal Transplant Recipients.

Authors:  Marie A Chisholm-Burns; Christina A Spivey; Praveen K Potukuchi; Elani Streja; Kamyar Kalantar-Zadeh; Csaba P Kovesdy; Miklos Z Molnar
Journal:  Nephron       Date:  2020-05-20       Impact factor: 2.847

Review 3.  Adjunct Digital Interventions Improve Opioid-Based Pain Management: Impact of Virtual Reality and Mobile Applications on Patient-Centered Pharmacy Care.

Authors:  Hayam Y Giravi; Zack Biskupiak; Linda S Tyler; Grzegorz Bulaj
Journal:  Front Digit Health       Date:  2022-06-13

4.  Adverse drug reactions, multimorbidity and polypharmacy: a prospective analysis of 1 month of medical admissions.

Authors:  Rostam Osanlou; Lauren Walker; Dyfrig A Hughes; Girvan Burnside; Munir Pirmohamed
Journal:  BMJ Open       Date:  2022-07-04       Impact factor: 3.006

5.  Real-time associations between young adults' momentary pain and prescription opioid misuse intentions in daily life.

Authors:  Lauren M Papp; Chrystyna D Kouros; John J Curtin
Journal:  Am Psychol       Date:  2020-09

Review 6.  Factors mediating pain-related risk for opioid use disorder.

Authors:  Arbi Nazarian; S Stevens Negus; Thomas J Martin
Journal:  Neuropharmacology       Date:  2021-01-30       Impact factor: 5.250

7.  Retrospective Chart Review of Advanced Practice Pharmacist Prescribing of Controlled Substances for Pain Management at the Harry S. Truman Memorial Veterans' Hospital.

Authors:  Courtney Kominek
Journal:  Fed Pract       Date:  2021-01

Review 8.  A Critical Review of the Social and Behavioral Contributions to the Overdose Epidemic.

Authors:  Magdalena Cerdá; Noa Krawczyk; Leah Hamilton; Kara E Rudolph; Samuel R Friedman; Katherine M Keyes
Journal:  Annu Rev Public Health       Date:  2021-11-30       Impact factor: 21.981

9.  Cross Disciplinary Role Agreement is Needed When Coordinating Long-Term Opioid Prescribing for Cancer: a Qualitative Study.

Authors:  K F Giannitrapani; M J Silveira; A Azarfar; P A Glassman; S J Singer; S M Asch; A M Midboe; M A Zenoni; R C Gamboa; W C Becker; K A Lorenz
Journal:  J Gen Intern Med       Date:  2021-05-04       Impact factor: 6.473

Review 10.  Musculoskeletal healthcare: Have we over-egged the pudding?

Authors:  Christopher G Maher; Mary O'Keeffe; Rachelle Buchbinder; I A Harris
Journal:  Int J Rheum Dis       Date:  2019-11       Impact factor: 2.454

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.